Skip to main content
Clinical Trials/NCT05884073
NCT05884073RecruitingNot Applicable

The Cost of Caring: Examining the Role of Exercise in Mitigating Oncology Care Provider Burnout (C4C+)

Melanie Keats3 sites in 1 country70 target enrollmentStarted: January 2, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
70
Locations
3
Primary Endpoint
Feasibility - Participant Fidelity (Intervention Adherence)

Study Overview

Brief Summary

The goal of this preference-based pilot study will be to assess the feasibility and acceptability, and impact of a 12-week exercise intervention on oncology care provider burnout. Participants self-select to participate into one of two exercise groups. Group assignment will be based on participant preference.

Group 1: Supervised circuit-based resistance exercise

Group 2: Nature-based walking

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years of age or older;
  • Able to speak/write in English;
  • Must be providing formal care to cancer patients in a clinical setting within the Halifax Municipality;
  • Actively practicing within the Nova Scotia Cancer Care Program; and
  • Able and willing to engage in low-to-moderate intensity physical activity.

Exclusion Criteria

  • Exceeding Canadian physical activity guidelines of 150-minutes of moderate-to-vigorous physical activity per week; and
  • Any health condition that would preclude safe participation in a new exercise program.

Arms & Interventions

Circuit-based resistance exercise

Experimental

12-week, supervised circuit-based resistance training program (2-3 times/week).

Intervention: Circuit-based Resistance Training (Behavioral)

Nature Walking

Active Comparator

12-weeks self-paced walking in nature (2-3 times/week).

Intervention: Nature-based Walking (Behavioral)

Outcomes

Primary Outcomes

Feasibility - Participant Fidelity (Intervention Adherence)

Time Frame: Through study completion (about 2 years)

Participant adherence to prescribed exercise intervention

Feasibility - Safety

Time Frame: Through study completion (about 2 years)

Adverse and serious adverse events

Feasibility - Retention/Attrition

Time Frame: Through study completion (about 2 years)

Percentage of participants who complete the 12-week intervention

Feasibility - Attendance

Time Frame: Through study completion (about 2 years)

Attendance is calculated as the percentage of exercise sessions completed by the total number of available exercise sessions over the 12-week intervention.

Feasibility - Recruitment

Time Frame: Through study completion (about 2 years)

Participant accrual as defined as the number of eligible participants who express an interest in participation divided by the number of participants who consent to participate.

Feasibility - Participant Experience

Time Frame: Through study completion (about 2 years)

Interviews with a diverse group of participants will be used to assess factors influencing participant selection of intervention type/setting, adherence to and satisfaction with the selected intervention.

Secondary Outcomes

  • Aerobic fitness(Pre to post intervention (12-week change))
  • Upper Body Strength(Pre to post intervention (12-week change))
  • Muscular Endurance(Pre to post intervention (12-week change))
  • Body Mass Index(Pre to post intervention (12-week change))
  • Maslach Burnout Inventory (MBI) for Medical Personnel (MP)(Baseline, mid-program (6-weeks), and post intervention (12-weeks).)
  • Physical Activity Behavior - Self-reported(Baseline, mid-program (6-weeks), and post intervention (12-weeks).)
  • Resting heart rate(Pre to post intervention (12-week change))
  • Resting Blood Pressure(Pre to post intervention (12-week change))

Investigators

Sponsor
Melanie Keats
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Melanie Keats

Principal Investigator

Nova Scotia Health Authority

Study Sites (3)

Loading locations...

Similar Trials